Ana Fernandez-Villegas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ana Fernandez-Villegas has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
- Gabriele Kaminski Schierle
Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK
10 shared publications - Clemens Friedrich Kaminski
Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK
8 shared publications - Manuel Carlos López
Instituto de Parasitologia y Biomedicina Lopez-Neyra, Consejo Superior de Investigaciones Científicas, Granada, Spain
6 shared publications - María Carmen Thomas
Instituto de Parasitologia y Biomedicina Lopez-Neyra, Consejo Superior de Investigaciones Científicas, Granada, Spain
6 shared publications - Bartolomé Carrilero
Unidad de Medicina Tropical, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
5 shared publications - Nino F. Laubli
Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom
5 shared publications
Latest Publications
- Open Access
- 13 November 2026
- Published by Springer Nature in Nature Communications
A microfluidic fluorescence lifetime screening platform bridges in vitro and in vivo formats and enables discovery of Amyloid β aggregation inhibitors
Inhibiting the aggregation of Amyloid β (1-42) is a promising strategy for the development of disease-modifying Alzheimer’s disease therapeutics. To date, however, no sufficiently efficacious inhibitors have been identified, despite the best efforts of more than 200 advanced drug development campaigns. This failure can be partially attributed to limitations in current in vitro compound screening and in vivo validation assays. Here, we report a high throughput assay platform based on the use of a fluorescence lifetime aggregation sensor that can be applied in vitro and in vivo. This microfluidic “nanoFLIM” assay presents a cost-effective and reliable alternative to conventional early-stage small molecule discovery platforms for cell-free Amyloid β aggregation. The fluorescence lifetime sensor can dynamically monitor peptide aggregation in cellular and Caenorhabditis elegans disease models, providing directly comparable aggregation kinetics, which is not achievable by any other method. The power of this unified platform for accelerating hit-to-lead strategies, lowering attrition rates and expediting in vivo screening, was demonstrated with a pilot screening campaign of 445 compounds, revealing an inhibitor that can inhibit Amyloid β self-assembly both in vitro as well as in cellular and whole organism disease models.
- 13 November 2026
- Published by Springer Nature in Nature Communications
Open AccessA microfluidic fluorescence lifetime screening platform bridges in vitro and in vivo formats and enables discovery of Amyloid β aggregation inhibitors
Inhibiting the aggregation of Amyloid β (1-42) is a promising strategy for the development of disease-modifying Alzheimer’s disease therapeutics. To date, however, no sufficiently efficacious inhibitors have been identified, despite the best efforts of more than 200 advanced drug development campaigns. This failure can be partially attributed to limitations in current in vitro compound screening and in vivo validation assays. Here, we report a high throughput assay platform based on the use of a fluorescence lifetime aggregation sensor that can be applied in vitro and in vivo. This microfluidic “nanoFLIM” assay presents a cost-effective and reliable alternative to conventional early-stage small molecule discovery platforms for cell-free Amyloid β aggregation. The fluorescence lifetime sensor can dynamically monitor peptide aggregation in cellular and Caenorhabditis elegans disease models, providing directly comparable aggregation kinetics, which is not achievable by any other method. The power of this unified platform for accelerating hit-to-lead strategies, lowering attrition rates and expediting in vivo screening, was demonstrated with a pilot screening campaign of 445 compounds, revealing an inhibitor that can inhibit Amyloid β self-assembly both in vitro as well as in cellular and whole organism disease models.
- Open Access
Discovery of TDP-43 aggregation inhibitors via a hybrid machine learning framework
TAR DNA-binding protein 43 (TDP-43) aggregation is a hallmark of several neurodegenerative diseases, including amyotrophic lateral sclerosis and frontotemporal dementia. Recent therapeutic efforts have highlighted the potential of small molecules capable of inhibiting TDP-43 aggregation; however, no effective treatments currently exist. Here, we developed a hybrid machine learning approach combining graph neural network (GNN) embeddings with traditional chemical descriptors and biological target annotations. Using XGBoost as the final classifier enabled model interpretability through SHAP analysis, allowing the identification of key chemical features and target annotations associated with TDP-43 anti-aggregation activity. Complementary Monte Carlo Tree Search analysis highlighted specific chemical substructures linked to predicted activity. By screening an external library of 3,853 small molecules, the model identified two compounds not previously evaluated against TDP-43 aggregation, namely berberrubine and PE859. Molecular docking analysis revealed that both compounds interact favourably with the TDP-43 RNA recognition motif (RRM) domain through distinct binding modes. Experimental validation showed that both compounds significantly reduced TDP-43 aggregation in HEK cells. Further testing in Caenorhabditis elegans expressing human TDP-43 demonstrated that PE859 significantly rescued locomotor defects, while berberrubine showed partial improvement. This work establishes a hybrid machine learning approach for accelerating small molecule drug discovery, yielding two promising therapeutic candidates for TDP-43 proteinopathies.
Open AccessDiscovery of TDP-43 aggregation inhibitors via a hybrid machine learning framework
TAR DNA-binding protein 43 (TDP-43) aggregation is a hallmark of several neurodegenerative diseases, including amyotrophic lateral sclerosis and frontotemporal dementia. Recent therapeutic efforts have highlighted the potential of small molecules capable of inhibiting TDP-43 aggregation; however, no effective treatments currently exist. Here, we developed a hybrid machine learning approach combining graph neural network (GNN) embeddings with traditional chemical descriptors and biological target annotations. Using XGBoost as the final classifier enabled model interpretability through SHAP analysis, allowing the identification of key chemical features and target annotations associated with TDP-43 anti-aggregation activity. Complementary Monte Carlo Tree Search analysis highlighted specific chemical substructures linked to predicted activity. By screening an external library of 3,853 small molecules, the model identified two compounds not previously evaluated against TDP-43 aggregation, namely berberrubine and PE859. Molecular docking analysis revealed that both compounds interact favourably with the TDP-43 RNA recognition motif (RRM) domain through distinct binding modes. Experimental validation showed that both compounds significantly reduced TDP-43 aggregation in HEK cells. Further testing in Caenorhabditis elegans expressing human TDP-43 demonstrated that PE859 significantly rescued locomotor defects, while berberrubine showed partial improvement. This work establishes a hybrid machine learning approach for accelerating small molecule drug discovery, yielding two promising therapeutic candidates for TDP-43 proteinopathies.
- Open Access
- 14 March 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (11) , eadr4155
PseudoSorter: A self-supervised spike sorting approach applied to reveal Tau-induced reductions in neuronal activity
Microelectrode arrays (MEAs) permit recordings with high electrode counts, thus generating complex datasets that would benefit from precise neuronal spike sorting for meaningful data extraction. Nevertheless, conventional spike sorting methods face limitations in recognizing diverse spike shapes. Here, we introduce PseudoSorter, which uses self-supervised learning techniques, a density-based pseudolabeling strategy, and an iterative fine-tuning process to enhance spike sorting accuracy. Through benchmarking, we demonstrate the superior performance of PseudoSorter compared to other spike sorting algorithms before applying PseudoSorter on MEA recordings from hippocampal neurons exposed to subneuronal concentrations of monomeric Tau as a model for Alzheimer’s disease. Our results unveil that Tau diminishes the firing rate of a subset of neurons, which complement our findings observed using conventional electrophysiology analysis, and demonstrate that PseudoSorter’s high accuracy and throughput make it a valuable tool for studying neurodegenerative diseases, enhancing our understanding of their underlying mechanisms, as well as for therapeutic drug screening.
- 14 March 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (11) , eadr4155
Open AccessPseudoSorter: A self-supervised spike sorting approach applied to reveal Tau-induced reductions in neuronal activity
Microelectrode arrays (MEAs) permit recordings with high electrode counts, thus generating complex datasets that would benefit from precise neuronal spike sorting for meaningful data extraction. Nevertheless, conventional spike sorting methods face limitations in recognizing diverse spike shapes. Here, we introduce PseudoSorter, which uses self-supervised learning techniques, a density-based pseudolabeling strategy, and an iterative fine-tuning process to enhance spike sorting accuracy. Through benchmarking, we demonstrate the superior performance of PseudoSorter compared to other spike sorting algorithms before applying PseudoSorter on MEA recordings from hippocampal neurons exposed to subneuronal concentrations of monomeric Tau as a model for Alzheimer’s disease. Our results unveil that Tau diminishes the firing rate of a subset of neurons, which complement our findings observed using conventional electrophysiology analysis, and demonstrate that PseudoSorter’s high accuracy and throughput make it a valuable tool for studying neurodegenerative diseases, enhancing our understanding of their underlying mechanisms, as well as for therapeutic drug screening.
- Open Access
Deep learning for fluorescence lifetime predictions enables high-throughput in vivo imaging
Fluorescence lifetime imaging microscopy (FLIM) is a powerful optical tool widely used in biomedical research to study changes in a sample’s microenvironment. However, data collection and interpretation are often challenging, and traditional methods such as exponential fitting and phasor plot analysis require a high number of photons per pixel for reliably measuring the fluorescence lifetime of a fluorophore. To satisfy this requirement, prolonged data acquisition times are needed, which makes FLIM a low-throughput technique with limited capability for in vivo applications. Here, we introduce FLIMngo, a deep learning model capable of quantifying FLIM data obtained from photon-starved environments. FLIMngo outperforms other deep learning approaches and phasor plot analyses, yielding accurate fluorescence lifetime predictions from decay curves obtained with fewer than 50 photons per pixel by leveraging both time and spatial information present in raw FLIM data. Thus, FLIMngo reduces FLIM data acquisition times to a few seconds, thereby, lowering phototoxicity related to prolonged light exposure and turning FLIM into a higher throughput tool suitable for analysis of live specimens. Following the characterisation and benchmarking of FLIMngo on simulated data, we highlight its capabilities through applications in live, dynamic samples. Examples include the quantification of disease-related protein aggregates in non-anaesthetised Caenorhabditis (C . ) elegans , which significantly improves the applicability of FLIM by opening avenues to continuously assess C. elegans throughout their lifespan. Finally, FLIMngo is open-sourced and can be easily implemented across systems without the need for model retraining.
Open AccessDeep learning for fluorescence lifetime predictions enables high-throughput in vivo imaging
Fluorescence lifetime imaging microscopy (FLIM) is a powerful optical tool widely used in biomedical research to study changes in a sample’s microenvironment. However, data collection and interpretation are often challenging, and traditional methods such as exponential fitting and phasor plot analysis require a high number of photons per pixel for reliably measuring the fluorescence lifetime of a fluorophore. To satisfy this requirement, prolonged data acquisition times are needed, which makes FLIM a low-throughput technique with limited capability for in vivo applications. Here, we introduce FLIMngo, a deep learning model capable of quantifying FLIM data obtained from photon-starved environments. FLIMngo outperforms other deep learning approaches and phasor plot analyses, yielding accurate fluorescence lifetime predictions from decay curves obtained with fewer than 50 photons per pixel by leveraging both time and spatial information present in raw FLIM data. Thus, FLIMngo reduces FLIM data acquisition times to a few seconds, thereby, lowering phototoxicity related to prolonged light exposure and turning FLIM into a higher throughput tool suitable for analysis of live specimens. Following the characterisation and benchmarking of FLIMngo on simulated data, we highlight its capabilities through applications in live, dynamic samples. Examples include the quantification of disease-related protein aggregates in non-anaesthetised Caenorhabditis (C . ) elegans , which significantly improves the applicability of FLIM by opening avenues to continuously assess C. elegans throughout their lifespan. Finally, FLIMngo is open-sourced and can be easily implemented across systems without the need for model retraining.
- Open Access
- 2 October 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 180, 117466
Sea cucumber-derived extract can protect skin cells from oxidative DNA damage and mitochondrial degradation, and promote wound healing
- 2 October 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 180, 117466
Open AccessSea cucumber-derived extract can protect skin cells from oxidative DNA damage and mitochondrial degradation, and promote wound healing
- Open Access
- 28 September 2024
- Published by Wiley in Advanced Science
- Vol. 11 (44) , e2402967
Graphene Microelectrode Arrays, 4D Structured Illumination Microscopy, and a Machine Learning Spike Sorting Algorithm Permit the Analysis of Ultrastructural Neuronal Changes During Neuronal Signaling in a Model of Niemann–Pick Disease Type C
Simultaneously recording network activity and ultrastructural changes of the synapse is essential for advancing understanding of the basis of neuronal functions. However, the rapid millisecond‐scale fluctuations in neuronal activity and the subtle sub‐diffraction resolution changes of synaptic morphology pose significant challenges to this endeavor. Here, specially designed graphene microelectrode arrays (G‐MEAs) are used, which are compatible with high spatial resolution imaging across various scales as well as permit high temporal resolution electrophysiological recordings to address these challenges. Furthermore, alongside G‐MEAs, an easy‐to‐implement machine learning algorithm is developed to efficiently process the large datasets collected from MEA recordings. It is demonstrated that the combined use of G‐MEAs, machine learning (ML) spike analysis, and 4D structured illumination microscopy (SIM) enables monitoring the impact of disease progression on hippocampal neurons which are treated with an intracellular cholesterol transport inhibitor mimicking Niemann–Pick disease type C (NPC), and show that synaptic boutons, compared to untreated controls, significantly increase in size, leading to a loss in neuronal signaling capacity.
- 28 September 2024
- Published by Wiley in Advanced Science
- Vol. 11 (44) , e2402967
Open AccessGraphene Microelectrode Arrays, 4D Structured Illumination Microscopy, and a Machine Learning Spike Sorting Algorithm Permit the Analysis of Ultrastructural Neuronal Changes During Neuronal Signaling in a Model of Niemann–Pick Disease Type C
Simultaneously recording network activity and ultrastructural changes of the synapse is essential for advancing understanding of the basis of neuronal functions. However, the rapid millisecond‐scale fluctuations in neuronal activity and the subtle sub‐diffraction resolution changes of synaptic morphology pose significant challenges to this endeavor. Here, specially designed graphene microelectrode arrays (G‐MEAs) are used, which are compatible with high spatial resolution imaging across various scales as well as permit high temporal resolution electrophysiological recordings to address these challenges. Furthermore, alongside G‐MEAs, an easy‐to‐implement machine learning algorithm is developed to efficiently process the large datasets collected from MEA recordings. It is demonstrated that the combined use of G‐MEAs, machine learning (ML) spike analysis, and 4D structured illumination microscopy (SIM) enables monitoring the impact of disease progression on hippocampal neurons which are treated with an intracellular cholesterol transport inhibitor mimicking Niemann–Pick disease type C (NPC), and show that synaptic boutons, compared to untreated controls, significantly increase in size, leading to a loss in neuronal signaling capacity.
- Open Access
- 15 May 2023
- Published by Springer Nature in Communications Biology
- Vol. 6 (1) , 1-13
α-Synuclein fibril and synaptic vesicle interactions lead to vesicle destruction and increased lipid-associated fibril uptake into iPSC-derived neurons
Monomeric alpha-synuclein (aSyn) is a well characterised protein that importantly binds to lipids. aSyn monomers assemble into amyloid fibrils which are localised to lipids and organelles in insoluble structures found in Parkinson’s disease patient’s brains. Previous work to address pathological aSyn-lipid interactions has focused on using synthetic lipid membranes, which lack the complexity of physiological lipid membranes. Here, we use physiological membranes in the form of synaptic vesicles (SV) isolated from rodent brain to demonstrate that lipid-associated aSyn fibrils are more easily taken up into iPSC-derived cortical i3Neurons. Lipid-associated aSyn fibril characterisation reveals that SV lipids are an integrated part of the fibrils and while their fibril morphology differs from aSyn fibrils alone, the core fibril structure remains the same, suggesting the lipids lead to the increase in fibril uptake. Furthermore, SV enhance the aggregation rate of aSyn, yet increasing the SV:aSyn ratio causes a reduction in aggregation propensity. We finally show that aSyn fibrils disintegrate SV, whereas aSyn monomers cause clustering of SV using small angle neutron scattering and high-resolution imaging. Disease burden on neurons may be impacted by an increased uptake of lipid-associated aSyn which could enhance stress and pathology, which in turn may have fatal consequences for neurons.
- 15 May 2023
- Published by Springer Nature in Communications Biology
- Vol. 6 (1) , 1-13
Open Accessα-Synuclein fibril and synaptic vesicle interactions lead to vesicle destruction and increased lipid-associated fibril uptake into iPSC-derived neurons
Monomeric alpha-synuclein (aSyn) is a well characterised protein that importantly binds to lipids. aSyn monomers assemble into amyloid fibrils which are localised to lipids and organelles in insoluble structures found in Parkinson’s disease patient’s brains. Previous work to address pathological aSyn-lipid interactions has focused on using synthetic lipid membranes, which lack the complexity of physiological lipid membranes. Here, we use physiological membranes in the form of synaptic vesicles (SV) isolated from rodent brain to demonstrate that lipid-associated aSyn fibrils are more easily taken up into iPSC-derived cortical i3Neurons. Lipid-associated aSyn fibril characterisation reveals that SV lipids are an integrated part of the fibrils and while their fibril morphology differs from aSyn fibrils alone, the core fibril structure remains the same, suggesting the lipids lead to the increase in fibril uptake. Furthermore, SV enhance the aggregation rate of aSyn, yet increasing the SV:aSyn ratio causes a reduction in aggregation propensity. We finally show that aSyn fibrils disintegrate SV, whereas aSyn monomers cause clustering of SV using small angle neutron scattering and high-resolution imaging. Disease burden on neurons may be impacted by an increased uptake of lipid-associated aSyn which could enhance stress and pathology, which in turn may have fatal consequences for neurons.
- Open Access
α-synuclein fibril and synaptic vesicle interactions lead to vesicle destruction and increased uptake into neurons
Monomeric alpha-synuclein (aSyn) is a well characterised as a lipid binding protein. aSyn is known to form amyloid fibrils which are also localised with lipids and organelles in so called Lewy bodies, insoluble structures found in Parkinson’s disease patient’s brains. It is still unclear under which conditions the aSyn-lipid interaction can start to become pathological. Previous work to address pathological interactions has focused on using synthetic lipid membranes, which lack the complexity of physiological lipid membranes which not only have a more complex lipid composition, but also contain lipid interacting proteins. Here, we investigate how either monomeric or fibrillar aSyn interact with physiological synaptic vesicles (SV) isolated from rodent brain. Using small angle neutron scattering and high-resolution imaging we observe that aSyn fibrils disintegrate SV, whereas aSyn monomers cause clustering of SV. Furthermore, SV enhance the aggregation rate of aSyn, however increasing the SV:aSyn ratio causes a reduction in aggregation propensity. SV lipids appear as an integrated part of aSyn fibrils and while the fibril morphology differs to aSyn fibrils alone, the core fibril structure remains the same. We finally demonstrate that lipid-associated aSyn fibrils are more easily taken up into cortical i 3 Neurons derived from induced pluripotent stem cells. Our study sheds light on differences between interactions of aSyn with synthetic lipid vesicles and physiological SV. We show how aSyn fibrils may enhance pathology by disintegrating SV, which in turn may have fatal consequences for neurons. Furthermore, disease burden may additionally be impacted by an increased uptake of lipid-associated aSyn by neurons, leading to more SV damage and enhancing aSyn aggregation.
Open Accessα-synuclein fibril and synaptic vesicle interactions lead to vesicle destruction and increased uptake into neurons
Monomeric alpha-synuclein (aSyn) is a well characterised as a lipid binding protein. aSyn is known to form amyloid fibrils which are also localised with lipids and organelles in so called Lewy bodies, insoluble structures found in Parkinson’s disease patient’s brains. It is still unclear under which conditions the aSyn-lipid interaction can start to become pathological. Previous work to address pathological interactions has focused on using synthetic lipid membranes, which lack the complexity of physiological lipid membranes which not only have a more complex lipid composition, but also contain lipid interacting proteins. Here, we investigate how either monomeric or fibrillar aSyn interact with physiological synaptic vesicles (SV) isolated from rodent brain. Using small angle neutron scattering and high-resolution imaging we observe that aSyn fibrils disintegrate SV, whereas aSyn monomers cause clustering of SV. Furthermore, SV enhance the aggregation rate of aSyn, however increasing the SV:aSyn ratio causes a reduction in aggregation propensity. SV lipids appear as an integrated part of aSyn fibrils and while the fibril morphology differs to aSyn fibrils alone, the core fibril structure remains the same. We finally demonstrate that lipid-associated aSyn fibrils are more easily taken up into cortical i 3 Neurons derived from induced pluripotent stem cells. Our study sheds light on differences between interactions of aSyn with synthetic lipid vesicles and physiological SV. We show how aSyn fibrils may enhance pathology by disintegrating SV, which in turn may have fatal consequences for neurons. Furthermore, disease burden may additionally be impacted by an increased uptake of lipid-associated aSyn by neurons, leading to more SV damage and enhancing aSyn aggregation.
- Open Access
- 7 January 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (1) , eabl4895
SARS-CoV-2 nucleocapsid protein adheres to replication organelles before viral assembly at the Golgi/ERGIC and lysosome-mediated egress
Super-resolution optical imaging reveals the accumulation of SARS-CoV-2 nucleocapsid protein at viral replication organelles.
- 7 January 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (1) , eabl4895
Open AccessSARS-CoV-2 nucleocapsid protein adheres to replication organelles before viral assembly at the Golgi/ERGIC and lysosome-mediated egress
Super-resolution optical imaging reveals the accumulation of SARS-CoV-2 nucleocapsid protein at viral replication organelles.
- Open Access
- 1 July 2020
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 295 (30) , 10138-10152
Intramitochondrial proteostasis is directly coupled to α-synuclein and amyloid β1-42 pathologies
- 1 July 2020
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 295 (30) , 10138-10152
Open AccessIntramitochondrial proteostasis is directly coupled to α-synuclein and amyloid β1-42 pathologies